Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Volatile fingerprints of cancer specific genetic mutations.

Nanomedicine : nanotechnology, biology, and medicine - 1 Aug 2013

Peled Nir, Barash Orna, Tisch Ulrike, Ionescu Radu, Broza Yoav Y, Ilouze Maya, Mattei Jane, Bunn Paul A, Hirsch Fred R, Haick Hossam

Abstract excerpt

We report on a new concept for profiling genetic mutations of (lung) cancer cells, based on the detection of patterns of volatile organic compounds (VOCs) emitted from cell membranes, using an array of nanomaterial-based sensors. In this in-vitro pilot study we have derived a volatile fingerprint assay for representative genetic mutations in cancer cells that are known to be associated with targeted cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biosensing Techniques
Share to DNA Fingerprinting

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nanostructures

Share to Oncogene Proteins, Fusion

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Share to Volatile Organic Compounds

Source

Open in PubMed Open full text

Identifiers

PMID: 23428987
DOI: 10.1016/j.nano.2013.01.008
PMCID: PMC4186653

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Volatile fingerprints of cancer specific genetic mutations.PMID 23428987Read ↗

Differentiation between genetic mutations of breast cancer by breath volatolomics.Semantic proximity Read ↗

Detection of Lung Cancer and EGFR Mutation by Electronic Nose System.Semantic proximity Read ↗

Unique volatolomic signatures of TP53 and KRAS in lung cells.Semantic proximity Read ↗

Breast cancer cohort study identifies an effective, non-invasive, breath-based diagnostic linked to cellular environment-dependent, novel methylation metabolismsSemantic proximity Read ↗

Revolutionizing Lung Cancer Detection: Evaluating AI Models for VOC Analysis and Unveiling Key Exhaled BiomarkersSemantic proximity Read ↗

Advancements in Early Cancer Detection: Toward Integrated, Longitudinal Precision ScreeningSemantic proximity Read ↗

Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer.Semantic proximity Read ↗

Volatilomic response to targeted cancer therapy in vitroSemantic proximity Read ↗

A dual-functional microfluidic chip for guiding personalized lung cancer medicine: combining EGFR mutation detection and organoid-based drug response test.Semantic proximity Read ↗

Engineering genetically-encoded synthetic biomarkers for breath-based cancer detectionSemantic proximity Read ↗

Profiling of Exhaled Volatile Organics in the Screening Scenario of a COVID-19 Test CenterSemantic proximity Read ↗

Single-cell genetic analysis of lung tumor cells based on self-driving micro-cavity array chip.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.